Posts

Drug Safety Communication: Ocaliva (obeticholic acid) - Serious Liver Injury Being Observed in Patients without Cirrhosis

Drug Safety Communication: Ocaliva (obeticholic acid) -...

Feb 9, 2025 0

Audience: Gastroenterology, Hepatology, Patient, Health Care Professional, Pharm...

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Endo USA, Inc. Issues Voluntary, Nationwide Recall of A...

Feb 9, 2025 0

Audience: Healthcare Professional, Pharmacy, Consumer MALVERN, PA, December 20, ...

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee Sugarlin Herbal Formula Due To Presence Of Undeclared Metformin And Glyburide

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fo...

Feb 9, 2025 0

Audience: Consumer December 16, 2024 – Los Angeles, California - Shoppers-Plaza ...

Astellas Issues Recall of One Lot of Prograf 0.5 mg and One Lot of Astagraf XL 0.5 mg Because Bottles Shipped to U.S. May Contain Empty Capsules

Astellas Issues Recall of One Lot of Prograf 0.5 mg and...

Feb 9, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer NORTHBROOK, IL, Dec. 23, 2024 ...

Alcon Laboratories Issues Voluntary Nationwide Recall of One Lot of Systane Lubricant Eye Drops Ultra PF Due to Fungal Contamination

Alcon Laboratories Issues Voluntary Nationwide Recall o...

Feb 9, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer December 21, 2024 – Fort Worth...

FDA Warns Health Care Professionals Not to Use Epinephrine Nasal Solutions from BPI Labs and Endo USA

FDA Warns Health Care Professionals Not to Use Epinephr...

Feb 9, 2025 0

Audience: Health Care Professionals January 16, 2025 -- FDA is warning health ca...

FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy

FDA Requires Guillain-Barré Syndrome (GBS) Warning in t...

Feb 9, 2025 0

Audience: Patient, Health Care Professional, Pharmacy, Immunology, Pulmonology I...

Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter

Provepharm Inc. Issues Recall of One Lot of Phenylephri...

Feb 9, 2025 0

Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Prov...

Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis

Drug Safety Communication: Copaxone, Glatopa (glatirame...

Feb 9, 2025 0

Audience: Patient, Caregiver, Health Care Professional, Pharmacy, Neurology ISSU...

Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System

Alvogen Issues Voluntary Nationwide Recall for One Lot ...

Feb 9, 2025 0

Audience: Consumer, Health Professional, Pharmacy January 31, 2025 – Morristown,...

Genentech’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson’s Disease

Genentech’s Phase IIb Study of Prasinezumab Missed Prim...

Feb 9, 2025 0

South San Francisco, CA -- December 18, 2024 -- Genentech, a member of the Roche...

Pila Pharma Announces XEN-D0501 Preclinical Proof-of-Concept Achieved In Cardiovascular Disease Study

Pila Pharma Announces XEN-D0501 Preclinical Proof-of-Co...

Feb 9, 2025 0

Malmö, Sweden 18 December 2024 PILA PHARMA AB (publ) (“PILA PHARMA” or the “Comp...

LimmaTech Awarded FDA Fast Track Designation for Vaccine Candidate Against Staphylococcus aureus

LimmaTech Awarded FDA Fast Track Designation for Vaccin...

Feb 9, 2025 0

SCHLIEREN, Switzerland--(BUSINESS WIRE)-- December 19, 2024 LimmaTech Biologics ...

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

Vertex Announces Results From Phase 2 Study of Suzetrig...

Feb 9, 2025 0

BOSTON--(BUSINESS WIRE)--Dec. 19, 2024-- Vertex Pharmaceuticals Incorporated (Na...

$Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia$

Nurix Therapeutics Receives U.S. FDA Fast Track Designa...

Feb 9, 2025 0

SAN FRANCISCO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasda...

Sapience Therapeutics Receives FDA Orphan Drug Designation for ST316, a First-in-Class β-catenin Antagonist, for the Treatment of Familial Adenomatous Polyposis (FAP)

Sapience Therapeutics Receives FDA Orphan Drug Designat...

Feb 9, 2025 0

TARRYTOWN, N.Y., December 19, 2024 – Sapience Therapeutics, Inc., a clinical-sta...

Gradalis’ GRAD1405 bi-shRNAi Candidate First to Show Positive Impact on Three Key KRAS Mutations Identified in Drug Resistant Lung, Colon and Pancreatic Cancers

Gradalis’ GRAD1405 bi-shRNAi Candidate First to Show Po...

Feb 9, 2025 0

DALLAS, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Gradalis Inc., a clinical-stage biotec...

NIH Researchers Discover Novel Class of Anti-Malaria Antibodies

NIH Researchers Discover Novel Class of Anti-Malaria An...

Feb 9, 2025 0

January 3, 2025 -- A novel class of antibodies that binds to a previously untarg...

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation

Axsome Therapeutics Announces Successful Completion and...

Feb 9, 2025 0

NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: A...

CagriSema Demonstrates Superior Weight Loss in Adults with Obesity or Overweight in the REDEFINE 1 Trial

CagriSema Demonstrates Superior Weight Loss in Adults w...

Feb 9, 2025 0

Bagsværd, Denmark, 20 December 2024 – Novo Nordisk today announced headline resu...

Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension

Mineralys Therapeutics Announces Phase 2 Clinical Trial...

Feb 9, 2025 0

RADNOR, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nas...

Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery

Vergent Bioscience Receives FDA Fast Track Designation ...

Feb 9, 2025 0

MINNEAPOLIS, Minn., January 7, 2025 – Vergent Bioscience, a clinical-stage biote...

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Crinetics Announces Positive Topline Results From Phase...

Feb 9, 2025 0

SAN DIEGO – January 10, 2025 – Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) to...

Research and Pipeline Research Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

Research and Pipeline Research Pfizer’s Sasanlimab in C...

Feb 9, 2025 0

NEW YORK--(BUSINESS WIRE)-- January 10, 2025 -- Pfizer Inc. (NYSE: PFE) today a...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.